From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
As of 1 September 2026, Australian clinicians no longer need specialist accreditation to prescribe hepatitis B antiviral treatments for initiation and maintenance therapy. In addition, authorised nurse prescribers can now prescribe hepatitis C medicine under the s100 program. This important reform follows sustained advocacy from ASHM, Hepatitis Australia and sector partners to improve timely and equitable access to treatment for […]
Maureen Lesley (left), Catholic Church Health Services Archdiocese of Madang Health Program Manager, and Dr Martin Daimen (right), Madang Provincial Health Authority Chief Executive Officer, sign the STEPT memorandum of understanding at the Madang Provincial Health Authority office. Preparations to bring the Supporting Triple Elimination in Papua New Guinea and Timor-Leste (STEPT) project to Madang […]
ASHM welcomes the Federal Government’s continued investment in HIV, blood-borne viruses (BBVs) and sexual health through the 2026–27 Federal Budget, including significant commitments to expand access to HIV prevention, treatment, medicines, infrastructure and hospital care across Australia. Investments in affordable HIV Pre-Exposure Prophylaxis (PrEP), continued support for universal access to HIV treatment, and broader funding […]
An introduction to this year’s C the Whole Story theme When we talk about “culturally safe” hepatitis C virus (HCV) care, what do we really mean? And how can creating a culturally safe environment improve treatment outcomes for people living with HCV? These questions form the foundation of this year’s C the Whole Story Forum, […]
Australia is on track to become the first nation to reach the target of eliminating cervical cancer by 2035, however, a decline in vaccination rates and cervical screening could put this in jeopardy. As a result, it is more important than ever for GPs to educate patients on the important role screening and vaccines play in the prevention of cervical cancer. […]
Overnight in 2016, the treatment of hepatitis C virus (HCV) in Australia changed forever through the introduction of Direct-acting antivirals (DAAs) to the Australian Pharmaceutical Benefits Scheme (PBS). This month marks ten years since this vital turning point. Prior to this, treatment for HCV typically took place in a hospital setting and scripts had to be written by a […]
As part of this year’s National Day of Women Living with HIV, we spoke with two long-time advocates, Del Batton and Kath Leane, about what women living with HIV most want from their clinicians. Their messages are clear: women living with HIV want healthcare workers who listen, stay informed, and recognise that women’s experiences of […]
From November last year, the NuvaRing is listed on the Pharmaceutical Benefits Scheme (PBS), allowing Australians subsidised access to another form of contraception. The NuvaRing is a contraceptive device that is inserted into the vagina and releases a combination of oestrogen and progesterone to inhibit ovulation and increase cervical mucous preventing sperm’s ability to penetrate the uterus. It is worn for three weeks at a time, before […]
On November 1, 2025, changes to the Medicare Benefits Schedule (MBS) came into effect that are intended to significantly reduce barriers to sexual and reproductive health (SRH) in Australia. These changes will see long-acting reversible contraceptives (LARC) become more affordable and accessible for patients, particularly those in vulnerable communities who may otherwise face barriers to SRH care. These changes are informed […]
For World AIDS Day Josh Borja, Senior Project Officer in ASHM’s National Policy and Education Division and Convenor of PANA (Positive Asian Network Australia), shares a reflection on his year working in the HIV sector. World AIDS Day is an annual reminder that progress in HIV care is measured not only in biomedical outcomes, but […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM